Skip to main content
Fig. 4 | BMC Infectious Diseases

Fig. 4

From: Characterization of HIV-1 molecular epidemiology and transmitted drug-resistance in newly diagnosed HIV-infected patients in Sichuan, China

Fig. 4

The resistance of HIV-1 to antiretroviral drugs. 3TC: lamivudine; ABC: abacavir; AZT: zidovudine; d4T: stavudine; ddI: didanosine; FTC: emtricitabine; TDF: tenofovir disoproxil fumarate; EFV: efavirenz; DOR: doravirine; NVP: nevirapine; RPV: Rilpivirine; ETR: etravirine; ATV/r: atazanavir/ritonavir; FPV/r: Fosamprenavir/ritonavir; IDV/r: indinavir/ritonavir; LPV/r: lopinavir/ritonavir, NFV: nelfinavir, SQV/r: saquinavir/ritonavir; TPV/r: tipranavir/ritonavir

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us